

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations origin...


(Alliance News) - London stocks slumped alongside Asian and European peers at Thursday's market open, as US tariff announcements and the prospect of t...


(Alliance News) - ValiRx PLC on Monday said it has decided to return the Dual Kinase project to Imperial College London for further development, and w...


(Sharecast News) - ValiRx announced on Monday that its wholly-owned subsidiary Inaphaea BioLabs has signed an evaluation and commercial use agreement ...


(Sharecast News) - ValiRx announced on Wednesday that it has entered into an evaluation and option agreement with Canada-based Altus Formulation to as...


(Sharecast News) - ValiRx, a life science company specialising in early-stage cancer therapeutics and women's health, announced a further amendment to...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.


(Alliance News) - ValiRx PLC on Tuesday said it has extended the exclusivity period for a proposed sub-license agreement with TheoremRx Inc for its VA...